ProCE Banner Activity

Podcast 1: Managing COVID-19 Risk in Individuals With Metabolic Syndrome and Obesity

Podcast Episodes

Listen as experts Donna Ryan, MD, and Renslow Sherer, MD, discuss the relationship between obesity and COVID-19, COVID-19 vaccines and antiviral therapy in the context of obesity and metabolic syndrome, and strategies to prevent or treat long COVID.

Released: October 02, 2023

Share

Faculty

Donna H. Ryan

Donna H. Ryan, MD

Professor Emerita
Pennington Biomedical Research Center
LSU
Baton Rouge, Louisiana

Renslow Sherer

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC. in partnership with Practicing Clinicians Exchange

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.

Faculty Disclosure

Primary Author

Donna H. Ryan, MD

Professor Emerita
Pennington Biomedical Research Center
LSU
Baton Rouge, Louisiana

Donna H. Ryan, MD: consultant/advisor/speaker: Altimune, Amgen, AstraZeneca, Biohaven, Boehringer Ingelheim, Calibrate, Carmot, CinRx, Currax, Epitomee, Fractl, Gila, Lilly, Nestle, Novo Nordisk, PPD, Regeneron, Scientific Intake; data and safety monitoring board: CinRx, IQVIA/Rhythm, Lilly; stock options: Calibrate, Epitomee, Ro, Scientific Intake, Xeno.

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Renslow Sherer, MD: researcher: Gilead.